Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

Abstract
No abstract available
Funding Information
  • astra zeneca
  • Johnson & Johnson
  • Janssen Pharmaceuticals
  • BI
  • Bayer
  • Johnson & Johnson
  • Bayer
  • Johnson & Johnson
  • Lilly
  • Boehringer
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol Myers-Squibb
  • Daiichi Sankyo
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Novartis
  • Sanofi
  • Pozen
  • Regado
  • Schering-Plough
  • The Medicines Company